Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, ...
A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from ...
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in ...
Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
On Mother’s Day, Clare Berry describes how her husband and two daughters carried her through eight months of dealing with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results